This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chang Gung University. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Innovative Contributions of Kuei-Tien Chen in Colorectal Cancer Detection
Introduction: Kuei-Tien Chen, based in Tao-Yuan, Taiwan, is an accomplished inventor recognized for his groundbreaking work in biomedical research. His pioneering patent focuses on developing serological markers for the early detection of colorectal cancer, greatly enhancing diagnostic processes in the medical field.
Latest Patents: Kuei-Tien Chen holds a patent titled "Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells." This patent outlines embodiments that involve markers indicating the presence of colorectal cancer through specific proteins, including phospholipid scramblase1 (PLSCR1), stomatin-like protein 2 (STOML2), and transport protein Sec61β (SEC61β). These proteins increase in expression in the blood during the early stages of colorectal cancer, providing critical diagnostic information. The patent details how detecting these proteins or their induced autoantibodies in blood samples can lead to improved sensitivity and efficiency in diagnosis, as well as better prognostic predictions.
Career Highlights: Kuei-Tien Chen is associated with Chang Gung University, a prestigious institution committed to advancing medical science and technology. His innovative research contributes significantly to the understanding and detection of colorectal cancer, establishing him as a key player in cancer research.
Collaborations: In his research endeavors, Kuei-Tien Chen collaborates with notable coworkers, including Err-Cheng Chan and Jau-Song Yu. Together, they aim to push the boundaries of diagnosis and treatment, leveraging their collective expertise in the fight against cancer.
Conclusion: Kuei-Tien Chen's innovative contributions to colorectal cancer detection through his patented serological markers demonstrate the potential of science in improving medical diagnostics. His work not only enhances early detection but also paves the way for advancements in treatment strategies, solidifying his impact in the field of biomedical research.